Birk Venture
9
4M
7
0.75
2
0.22
3
- Areas of investment
Summary
Birk Venture is the famous VC, which was founded in 2010. The fund was located in Europe if to be more exact in Norway. The main department of described VC is located in the Oslo.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Birk Venture, startups are often financed by Sarsia Seed Management. The meaningful sponsors for the fund in investment in the same round are Sarsia Seed Management, TeleVenture Management. In the next rounds fund is usually obtained by Investinor, Sarsia Seed Management, Trygve Schiorbeck.
We also calculated 1 valuable employee in our database.
The top activity for fund was in 2011. The top amount of exits for fund were in 2017. Speaking about the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Birk Venture performs on 0 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Norway. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight APIM Therapeutics, Targovax, BerGenBio. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Finance.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 2
- Exits
- 3
- Rounds per year
- 0.75
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (7)
- Medical (4)
- Pharmaceutical (3)
- Therapeutics (2)
- Finance (2) Show 4 more
- Investments by region
-
- United Kingdom (2)
- Norway (7)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.56
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Accession Therapeutics Limited | 21 Nov 2022 | Biopharma | Early Stage Venture | 22M | Oxfordshire, Oxford, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.